High-density lipoprotein (HDL) in older patients with schizophrenia: implications for clinical and cognitive outcomes

Key Points

• Higher levels of high-density lipoprotein are linked to better cognitive outcomes in older patients with schizophrenia.
• The analysis revealed a significant correlation between HDL and cognition, with HDL levels impacting clinical assessment scores.
• Observational analysis focusing on older individuals diagnosed with schizophrenia examined lipid metabolism and associated cognitive effects.
• These findings highlight the potential for HDL as a biomarker influencing clinical and cognitive strategies in older schizophrenia patients.